Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd (formerly Roxy Exports Limited) has informed BSE that its Board of Directors will meet on Monday, August 4, 2025, to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The company has also closed its trading window for insiders from July 1, 2025, until 48 hours after the results are declared, as per SEBI insider trading rules. This is a routine regulatory intimation under SEBI Listing Regulations and does not contain any financial figures. The intimation is signed by Adarsh Munjal, Whole Time Director.
No direct impact on shareholders from this filing — it is a standard advance notice of upcoming results. Investors should watch the August 4, 2025 results announcement for actual revenue, profit, and margin numbers that could move the stock.